| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.53 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |